Access and Rational use of Plasma Protein Therapies (PPTs)

Journal Title: Iranian Journal of Blood and Cancer - Year 2011, Vol 3, Issue 3

Abstract

This article has no abstract.

Authors and Affiliations

Albert Farrugia

Keywords

Related Articles

Effect of Pamidronate on Osteoporosis in Patients with β-Thalassemia Major

Background: β-thalassemia major is a hereditary life threatening anemia which requires regular blood transfusion. Clinical symptoms of the disease are growth retardation, pallor, jaundice and skeletal alternations. The v...

Beta-Globin Gene Cluster Haplotypes in Iranian Sickle Cell Patients: Relation to Some Hematologic

Background: Sickle cell anemia is relatively common in Khuzestan province located in Southwest Iran. The characteristics of sickle cell disease in Iran are apparently different from other regions some of these characteri...

Methylation Status of SOX17 and RUNX3 Genes in Acute Leukemia

Background: Several studies have examined the presence of DNA methylation of CpG islands in leukemia. Methylation of SOX17 and RUNX3 genes may play a role in leukemogenesis through silencing tumor suppressor genes. We in...

Density of Platelet GPIIb-IIIa and Bleeding Severity in Iranian Patients with Glanzmann’s Thrombasthenia

Background: Glanzmann’s Thrombasthenia (GT) is a rare autosomal, recessive, bleeding syndrome. The main aim of this study was to investigate the relationship between symptoms, bleeding severity, and gender and subtypes o...

Studies of Human HbAA Erythrocyte Osmotic Fragility Index of Non-Malarious Blood in the Presence of Five Anti-malarial Drugs

Background: The capacity of human HbAA erythrocytes of non-malarious blood to withstand osmotic stress in the presence of five antimalarial drugs, Chloroquine phosphate, Quinine, FansidarTM, CoartemTM and HalfanTM was st...

Download PDF file
  • EP ID EP370822
  • DOI -
  • Views 57
  • Downloads 0

How To Cite

Albert Farrugia (2011). Access and Rational use of Plasma Protein Therapies (PPTs). Iranian Journal of Blood and Cancer, 3(3), 151-158. https://europub.co.uk/articles/-A-370822